LABD ETF

LABD ETF
$5.98
See how much of LABD you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$61M
Expense Ratio
1.07%
Dividend Yield (Current)
4.50%
Holdings
10
Inception Date
May 28, 2015
Fund Family
Direxion Shares ETF Trust
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly

Performance

YTD-55.66%
1 Year-85.58%
3 Year-57.92%
5 Year-46.55%
10 Year-56.68%

Asset Allocation

Other: 207.95%
See how much of LABD you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
FTIXXGoldman Finl Sq Trsry Inst 50673.75%
DGCXXDreyfus Govt Cash Man Ins49.19%
FGTXXGoldman Sachs Fin Gov 465 Institut21.76%
DIRXXDreyfus Trsry Securities Cash Mgmt11.04%
-Sold INR Bought USD 20260407-12.72%
Report Date: Jun 30, 2026
Download all 10 holdings for LABD
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
4.50%
Frequency
Quarterly
Latest Distribution
$0.08
Jun 23, 2026
12M Distributions
4 payments
Total: $0.42

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This ETF
PRO
Peer Avg
PRO

LABD ETF Overview

LABD ETF (Direxion Daily S&P Biotech Bear 3X ETF) is managed by Direxion Shares ETF Trust with $60.9M in net assets. LABD expense ratio is 1.07%, holding 10 positions across sectors including Financials. Inception date: 2015-05-28.

LABD performance shows a YTD return of -55.66%. The 1-year return is -85.58% and the 5-year return is -46.55%. LABD dividend yield stands at 4.50%, paid quarterly.

LABD top holdings include Goldman Finl Sq Trsry Inst 506 (73.8%), Dreyfus Govt Cash Man Ins (49.2%), Goldman Sachs Fin Gov 465 Institut (21.8%), Dreyfus Trsry Securities Cash Mgmt (11.0%), Sold INR Bought USD 20260407 (-12.7%). Go to all LABD holdings, LABD sectors, or LABD dividends.

LABD can be compared against other funds. Use LABD overlap to find shared positions, or LABD vs another fund for a side-by-side view. LABD alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
+20.97%
YTD
-55.66%
1 Year
-85.58%
3 Year
-57.92%

Top 10 Holdings (net short exposure of 278% (≈-3x))

#TickerNameSectorWeight
1FTIXXGoldman Finl Sq Trsry Inst 506Unknown73.75%
2DGCXXDreyfus Govt Cash Man InsFinancials49.19%
3FGTXXGoldman Sachs Fin Gov 465 InstitutFinancials21.76%
4DIRXXDreyfus Trsry Securities Cash MgmtUnknown11.04%
5-Sold INR Bought USD 20260407Other-12.72%
6-Freddie Mac Pool Qd3473 2.00% 12/1/2051Other-21.49%
7-Sold KRW Bought USD 20260415Other-24.92%
8-S&P Biotechnology Select IndusTRY Index SwapOther-37.07%
9-S&P Biotechnology Select IndusTRY Index SwapOther-67.01%
10-Currency Contract - ZAROther-136.79%